THURSDAY, September 24, 2015 (CBS News) — Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests.
In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening has dropped by 28 percent, the researchers report.
You might have also missed…
Sandra Lee is back, says she’s ‘cancer-free’ Sept 22, USA Today This article includes a tweet from the Prevent Cancer Foundation!
Colorectal Cancer Sept 23, Williamson Daily News
What to know before getting the genetic test for breast cancer Sept 24, Chicago Tribune